The Trust has equipped all District nurse bags with a box of Debrisoft and has held a meeting with the Debrisoft Rep to discuss the issues when raising a prescription through the GP surgery. The Debrisoft Rep is liaising with GP surgeries and local pharmacies in order to cascade educational advice regarding product and FP10. (AI summary)
View full response
Re: Response to Regulations 28 Report to Prevent Future Deaths – The late Mr Philip John Powell
I am in receipt of your Regulation 28 Report to Prevent Future Deaths following the inquest and your ruling on 30 November 2017, in respect of the late Philip John Powell. I should extend again the condolences of the Trust to Mr Powell’s family.
The MATTERS OF CONCERN are as follows –
1. Evidence emerged during the inquest that there were delays in ordering Debrisoft which may have helped in managing the wound.
In addition, there was evidence of poor communication and poor systems in place in ordering Debrisoft with confusion about the process and overall responsibility.
The important issues you raise have been taken very seriously within the Trust and I enclose an action plan which confirms: a) the actions taken by the Trust in response to your concerns: b) the target dates for completion of those actions; and c) the officers with responsibility for progress of the actions.
I trust the information provides assurances to you that the Trust has taken appropriate action to mitigate any further patient safety issues with regards to timely procurement and availability of this product in future.